BioCatalyst

BI-1206, Rituximab, Acalabrutinib — catalyst calendar

1 verified catalyst event(s) referencing BI-1206, Rituximab, Acalabrutinib, each linked to its official source. Verified as of 2026-06-22.

Upcoming

DateEventCompanyDrugOfficial source & verification
2026-09-30
in 3mo
ESTIMATED
 READOUT
A Study of BI-1206 in Combination With Rituximab With or Without Acalabrutinib i
Phase 1/2 · Indolent B-Cell Non-Hodgkin Lymphoma
 BioInvent International AB BI-1206, Rituximab, Acalabrutinib ClinicalTrials.gov ↗
✓ Source-checked 2026-06-22
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.